Corenth applies machine learning to blood bank and plasma center operations — forecasting demand, minimizing expiry waste, predicting donor retention, and automating regulatory traceability.
Demand spikes are unpredictable. Inventory expires. Donors churn. Regulatory audits are manual. Each of these failures costs lives and millions — yet the industry still runs on spreadsheets and intuition.
Corenth plugs into existing blood bank LIS and donor management systems. No rip-and-replace — just an intelligence layer on top.
Each module works standalone or as a unified system across blood banks and plasma centers.
Predicts blood product demand 7–21 days ahead at blood type and product-level granularity. Integrates hospital surgical schedules, emergency intake patterns, and seasonal disease epidemiology.
Tracks every unit in real-time against forecasted demand, surfacing redistribution and issuing prioritization decisions that cut discard rates by up to 30%.
Identifies donors at risk of lapsing before they do, enabling proactive outreach campaigns and optimizing collection drive targeting for maximum yield per contact.
Full chain-of-custody logging from donor identification through transfusion, generating FDA 21 CFR Part 606 and EU Blood Directive–compliant reports automatically.
Three convergent shifts are making this the only viable moment to build.
Every day a blood shortage occurs, the system has already failed.
Rishi Maddi founded Corenth after spending years studying how preventable operational failures cascade into patient harm. The blood supply chain is one of the most structurally critical — and operationally archaic — systems in modern healthcare. Virtually every major inefficiency in it is solvable with today's AI stack.
Rishi brings together deep expertise in machine learning, healthcare data infrastructure, and supply chain systems. His conviction is simple: the tools to eliminate blood shortages and expiry waste already exist. What's been missing is someone willing to build specifically for this domain, with the regulatory sensitivity and systems integration depth it demands.
"Blood banks are sitting on years of rich operational data. They just have no system to turn it into decisions. That's precisely what Corenth is built to be."
Corenth is being built with direct input from blood bank operations directors, transfusion medicine physicians, and compliance officers — ensuring every feature earns its place in a high-stakes clinical workflow.
The blood bank software market is growing at 8.5% CAGR — but legacy vendors still dominate with workflow tools, not intelligence.
Corenth is accepting a limited cohort of pilot partners in 2025. Blood banks and plasma centers with 50,000+ annual units collected are invited to apply.